Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07ADX
|
||||
Former ID |
DIB021139
|
||||
Drug Name |
URMC-099
|
||||
Synonyms |
compound 1 [PMID 24044867]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [532479] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H27N5
|
||||
InChI |
InChI=1S/C27H27N5/c1-31-10-12-32(13-11-31)18-19-2-4-20(5-3-19)23-15-24-25(17-30-27(24)29-16-23)21-6-7-26-22(14-21)8-9-28-26/h2-9,14-17,28H,10-13,18H2,1H3,(H,29,30)
|
||||
InChIKey |
QKKIWEILHCXECO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | leucine-rich repeat kinase 2 | Target Info | Inhibitor | [532479] | |
cyclin-dependent kinase-like 2 (CDC2-related kinase) | Target Info | Inhibitor | [532479] | ||
Mitogen-activated protein kinase kinase kinase 11 | Target Info | Inhibitor | [532479] | ||
Mitogen-activated protein kinase kinase kinase 2 | Target Info | Inhibitor | [532479] | ||
death-associated protein kinase 3 | Target Info | Inhibitor | [532479] | ||
SRSF protein kinase 2 | Target Info | Inhibitor | [532479] | ||
Mitogen-activated protein kinase kinase kinase 9 | Target Info | Inhibitor | [532479] | ||
Mitogen-activated protein kinase kinase kinase 10 | Target Info | Inhibitor | [532479] | ||
FL cytokine receptor | Target Info | Inhibitor | [532479] | ||
KEGG Pathway | MAPK signaling pathway | ||||
Non-alcoholic fatty liver disease (NAFLD)hsa04010:MAPK signaling pathway | |||||
Gap junction | |||||
GnRH signaling pathwayhsa04060:Cytokine-cytokine receptor interaction | |||||
Hematopoietic cell lineage | |||||
Pathways in cancer | |||||
Transcriptional misregulation in cancer | |||||
Acute myeloid leukemia | |||||
Central carbon metabolism in cancer | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.